(Q33570512)

English

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Adaptive radiation therapy

0 references

1 reference

based on heuristic

head and neck cancer

1 reference

based on heuristic

1 reference

based on heuristic

advanced head and neck cancer

1 reference

based on heuristic

1 reference

based on heuristic

head and neck carcinoma

1 reference

based on heuristic

object named as

Mattheos Bobos

7

0 references

Konstantinos Markou

object named as

Konstantinos Markou

12

0 references

George Fountzilas

1

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

4

object named as

Ralph M Wirtz

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Vassiliki Kotoula

8

object named as

Vassiliki Kotoula

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Konstantine T Kalogeras

15

object named as

Konstantine T Kalogeras

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A Kalogera-Fountzila

2

object named as

Anna Kalogera-Fountzila

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Angelos Nikolaou

5

object named as

Angelos Nikolaou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Georgia Karayannopoulou

6

object named as

Georgia Karayannopoulou

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Gerasimos Aravantinos

11

object named as

Gerasimos Aravantinos

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Sophia Lambaki

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Samuel Murray

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Alexandros Lambropoulos

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Eleni Athanassiou

13

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Despina Misailidou

14

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Demosthenis Skarlos

16

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

29 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of oncology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

305908

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

The role of PET-CT in the management of patients with advanced cancer of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Human papillomavirus in cervical and head-and-neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

The role of matrix metalloproteinases in stromal/epithelial interactions in the gut.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Chemoradiotherapy for locally advanced head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Evolving strategies for combined-modality therapy for locally advanced head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

The concurrent chemoradiation paradigm--general principles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Presence of human papillomavirus type 18 DNA in a pharyngeal and a laryngeal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

21 June 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

[Frequency and distribution pattern of distant metastases in patients with ENT tumors and their consequences for pretherapeutic staging].

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Clinical and molecular prognostic factors in operable laryngeal cancer.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

31 October 2018

Human papillomavirus frequency in oral and oropharyngeal cancer in Greece.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

31 October 2018

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801452

31 October 2018

Epidermal Growth Factor Receptor Expression in Pretreatment Biopsies From Head and Neck Squamous Cell Carcinoma As a Predictive Factor for a Benefit From Accelerated Radiation Therapy in a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F305908

21 January 2018

Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor family and chemosensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carc

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential multilocus fluorescence in situ hybridization can detect complex patterns of increased gene dosage at the single cell level in tissue sections

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integration of EGFR inhibitors with radiochemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locoregional failure analysis in head-and-neck cancer patients treated with IMRT

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20066159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2009/305908

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33570512&oldid=2071979131"